These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26381259)

  • 41. Germline CDKN2A mutation implicated in predisposition to multiple myeloma.
    Dilworth D; Liu L; Stewart AK; Berenson JR; Lassam N; Hogg D
    Blood; 2000 Mar; 95(5):1869-71. PubMed ID: 10688850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.
    Soufir N; Lacapere JJ; Bertrand G; Matichard E; Meziani R; Mirebeau D; Descamps V; Gérard B; Archimbaud A; Ollivaud L; Bouscarat F; Baccard M; Lanternier G; Saïag P; Lebbé C; Basset-Seguin N; Crickx B; Cave H; Grandchamp B
    Br J Cancer; 2004 Jan; 90(2):503-9. PubMed ID: 14735200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial melanoma, pancreatic cancer and germline CDKN2A mutations.
    Goldstein AM
    Hum Mutat; 2004 Jun; 23(6):630. PubMed ID: 15146471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
    Vasen HF; Gruis NA; Frants RR; van Der Velden PA; Hille ET; Bergman W
    Int J Cancer; 2000 Sep; 87(6):809-11. PubMed ID: 10956390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations.
    Jovanovic B; Egyhazi S; Eskandarpour M; Ghiorzo P; Palmer JM; Bianchi Scarrà G; Hayward NK; Hansson J
    J Invest Dermatol; 2010 Feb; 130(2):618-20. PubMed ID: 19759551
    [No Abstract]   [Full Text] [Related]  

  • 46. Familial melanoma and pancreatic cancer.
    Wright FA; Thomas RG
    N Engl J Med; 1996 Feb; 334(7):470-1; author reply 471-2. PubMed ID: 8552159
    [No Abstract]   [Full Text] [Related]  

  • 47. Germline CDKN2A/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients.
    Lukowsky A; Schäfer-Hesterberg G; Sterry W; Voit C
    J Dermatol Sci; 2008 Feb; 49(2):163-5. PubMed ID: 17890059
    [No Abstract]   [Full Text] [Related]  

  • 48. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.
    Whelan AJ; Bartsch D; Goodfellow PJ
    N Engl J Med; 1995 Oct; 333(15):975-7. PubMed ID: 7666917
    [No Abstract]   [Full Text] [Related]  

  • 49. Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT.
    Daniotti M; Ferrari A; Frigerio S; Casieri P; Miselli F; Zucca E; Collini P; Della Torre G; Manoukian S; Peissel B; Bono A; Santinami M; Parmiani G; Rivoltini L; Pilotti S; Rodolfo M
    J Invest Dermatol; 2009 Jul; 129(7):1759-68. PubMed ID: 19158841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age does not appear to be a major indicator of CDKN2A or CDK4 mutations in melanoma patients in Spain.
    Nagore E; Montoro A; Oltra S; Ledesma E; Botella-Estrada R; Millán JM; Oliver V; Fortea JM; Guillén C
    Melanoma Res; 2005 Dec; 15(6):555-8. PubMed ID: 16314743
    [No Abstract]   [Full Text] [Related]  

  • 51. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
    Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
    J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
    [No Abstract]   [Full Text] [Related]  

  • 52. Malignant and benign tumors associated with multiple primary melanomas: just the starting block for the involvement of MITF, PTEN and CDKN2A in multiple cancerogenesis?
    Pollio A; Tomasi A; Seidenari S; Pellacani G; Rodolfo M; Frigerio S; Maurichi A; Turchetti D; Bassoli S; Ruini C; Ponti G
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):755-7. PubMed ID: 23802662
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
    Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
    Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The lack of E318K MITF germline mutation in Latvian melanoma patients.
    Ozola A; Pjanova D
    Cancer Genet; 2015 Jun; 208(6):355-6. PubMed ID: 25975176
    [No Abstract]   [Full Text] [Related]  

  • 55. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L; Grossman D; Leachman SA
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT.
    Taylor NJ; Mitra N; Qian L; Avril MF; Bishop DT; Bressac-de Paillerets B; Bruno W; Calista D; Cuellar F; Cust AE; Demenais F; Elder DE; Gerdes AM; Ghiorzo P; Goldstein AM; Grazziotin TC; Gruis NA; Hansson J; Harland M; Hayward NK; Hocevar M; Höiom V; Holland EA; Ingvar C; Landi MT; Landman G; Larre-Borges A; Mann GJ; Nagore E; Olsson H; Palmer JM; Perić B; Pjanova D; Pritchard AL; Puig S; Schmid H; van der Stoep N; Tucker MA; Wadt KAW; Yang XR; Newton-Bishop JA; Kanetsky PA;
    J Am Acad Dermatol; 2019 Aug; 81(2):386-394. PubMed ID: 30731170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations.
    Yang XR; Rotunno M; Xiao Y; Ingvar C; Helgadottir H; Pastorino L; van Doorn R; Bennett H; Graham C; Sampson JN; Malasky M; Vogt A; Zhu B; Bianchi-Scarra G; Bruno W; Queirolo P; Fornarini G; Hansson J; Tuominen R; Burdett L; Hicks B; Hutchinson A; Jones K; Yeager M; Chanock SJ; Landi MT; Höiom V; Olsson H; Gruis N; Ghiorzo P; Tucker MA; Goldstein AM
    Hum Genet; 2016 Nov; 135(11):1241-1249. PubMed ID: 27449771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population.
    Berwick M; Begg CB; Armstrong BK; Reiner AS; Thomas NE; Cook LS; Orlow I; Kricker A; Marrett LD; Gruber SB; Anton-Culver H; Millikan RC; Gallagher RP; Dwyer T; Rosso S; Kanetsky PA; Lee-Taylor J
    J Invest Dermatol; 2011 Dec; 131(12):2500-3. PubMed ID: 21833009
    [No Abstract]   [Full Text] [Related]  

  • 59. Association of melanoma with intraepithelial neoplasia of the pancreas in three patients.
    Fidalgo F; Gomes EE; Moredo Facure L; Da Silva FC; Carraro DM; de Sá BC; Duprat Neto JP; Krepischi AC
    Exp Mol Pathol; 2014 Aug; 97(1):144-7. PubMed ID: 24984283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CM-Score: a validated scoring system to predict
    Potjer TP; Helgadottir H; Leenheer M; van der Stoep N; Gruis NA; Höiom V; Olsson H; van Doorn R; Vasen HFA; van Asperen CJ; Dekkers OM; Hes FJ;
    J Med Genet; 2018 Oct; 55(10):661-668. PubMed ID: 29661971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.